Clinical Financial Statements From 2010 to 2025
| CLS-B Stock | SEK 3.40 0.04 1.19% |
Check Clinical Laserthermia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clinical Laserthermia's main balance sheet or income statement drivers, such as , as well as many indicators such as . Clinical financial statements analysis is a perfect complement when working with Clinical Laserthermia Valuation or Volatility modules.
Clinical |
Clinical Laserthermia Systems Company Current Valuation Analysis
Clinical Laserthermia's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clinical Laserthermia Current Valuation | 73.29 M |
Most of Clinical Laserthermia's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clinical Laserthermia Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clinical Laserthermia Systems has a Current Valuation of 73.29 M. This is 99.49% lower than that of the Healthcare sector and 99.41% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 99.56% higher than that of the company.
Clinical Laserthermia Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clinical Laserthermia's current stock value. Our valuation model uses many indicators to compare Clinical Laserthermia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clinical Laserthermia competition to find correlations between indicators driving Clinical Laserthermia's intrinsic value. More Info.Clinical Laserthermia Systems is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clinical Laserthermia's earnings, one of the primary drivers of an investment's value.About Clinical Laserthermia Financial Statements
Clinical Laserthermia shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Clinical Laserthermia investors may analyze each financial statement separately, they are all interrelated. The changes in Clinical Laserthermia's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clinical Laserthermia's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.